Since Gowans first discovered the importance of lymphocytes in the immune response [1], a gradual understanding of their biology has evolved. Initially, B lymphocytes, the effector cells of humoral immunity, were studied in great detail. Largely because of the ability to obtain huge quantities of homogeneous antibodiesthe B cell's primary product-through the study of multiple myeloma, tremendous gains were made in understanding the B lymphocyte's active role in immunity.
gains were made in understanding the B lymphocyte's active role in immunity. The T cell, however, remained more intractable; without the ease of obtaining an entity analogous to an antibody molecule, other approaches were necessary. The biology of cytotoxic T lymphocytes was studied by examining their ability to lyse foreign cells. Yet the cells which are most important in understanding the physiologic control of the immune response, the regulatory T lymphocytes, have been the most difficult to comprehend.
In June of 1979, a symposium sponsored by Columbia University was held on this topic, bringing together most of the world's experts in this area. The proceedings of this meeting, the fourth of the P. and S. Biomedical Sciences Symposia, edited by Benvenuto Pernis and Henry J. Vogel, represents an outstanding summary of work in this field.
The volume is divided into seven sections, initially examining T cell receptors and T subpopulations before going into detailed discussions of both murine and human helper and suppressor T lymphocytes. Finally, regulatory T cell circuits are described in an attempt to synthesize present knowledge in the area into a coherent model.
The book first examines one of the more basic yet elusive characteristics of T lymphocytes, the T cell receptor, determinant of T cell specificity. Although it is well documented that T lymphocytes do not bear conventional immunoglobulin molecules or intact L chains, it has been elegantly shown that they do express idiotypic determinants shared by B cells specific for the same antigen. One approach described has been to try to propagate clones of T cells which secrete soluble molecules mediating their antigen-specific regulatory functions, analogous to studying B cells through their immunoglobulins.
Another approach to studying T lymphocytes has been to take advantage of the cell surface differentiation antigens which are specific for various sub-classes of T lymphocytes. With the use of monoclonal antibodies against these markers, a more detailed analysis of T function can be performed. Employing a fluorescence-activated cell sorter, for example, one is able to determine the fraction of cells expressing a given differentiation antigen in a population, and to correlate such structural information with the cell's function. Furthermore, these antibodies can be used selectively to enrich or deplete a given subpopulation of cells, or to interfere with their actions, providing more information on the function associated with such a subset.
While work on regulatory T cells was initially confined to animal systems, recent work has correlated data obtained from various species to that from humans; this is particularly evident in the area of disorders in regulation. For example, a wide range of immune deficiency diseases have now been ascribed to the presence of abnormally large numbers or overly activated suppressor T cells; at the other extreme, depletion of suppressor cell activity has been implicated in autoimmune disorders. It has also been claimed that suppressor cells play a role in the immunologic enhancement of tumor growth. Each of these imbalances in regulation, it may be added, also suggests potential avenues for immunoprophylaxis or immunotherapy.
The final section of the volume is devoted to discussions of regulatory T circuits in an effort to consolidate the experimental data into an understanding of the physiologic control of the immune response. Employing the concept of "id^" and "id" T regulatory cells (for those T lymphocytes bearing idiotypes either identical or complementary to that of the B cell being controlled), Herzenberg et al. have proposed the concept of the core regulatory circuit. In it, two sets of helper T cells and two sets of suppressor T cells modulate each other in a cyclic fashion, the outcome of which determines whether a given B lymphocyte is helped or suppressed. Presumably all soluble factor-and macrophage-mediated interactions affecting B cell response do so by altering the equilibrium of this four-cell circuit. As with Jerne's original formulation of a network hypothesis to explain immune regulation [2] , such a theory represents a good framework from which to ask future questions and to build a more comprehensive model of lymphocyte interactions.
The constantly changing nature of cellular immunology makes it difficult for any one book to cover the field adequately. However, the papers in this volume, which are uniformly well written, present new data as well as summarize years of previous work by most of the leading laboratories in the area. As such, this volume represents an excellent, fairly up-to-date review of regulatory T cells, as well as a useful guide to new work in this rapidly emerging field. Lazo, and Joseph R. Bertino. New York, Academic Press, Inc., Publishers, 1981. 598 pp. $45.00.
The Second Annual Bristol-Myers Symposium on Cancer Research was truly a whirlwind affair. Hosted by the Yale University Department of Pharmacology and the Developmental Therapeutics Program of the Comprehensive Cancer Center, twenty-nine internationally known scientists presented papers to nearly five hundred participants over two days (November 8-9, 1979) at the Sheraton-Park Plaza Hotel in New Haven, CT. The effects of such a program on this reviewer were exhilarating yet unsatisfying. Limited to twenty minutes for presentation and a fifteen-minute panel discussion at the end of a session, each lecturer worked crisply to lay down the fundamentals of the research and hoped to break some new ground before time expired. Any temptation to pause and reflect must be strongly suppressed during this type of rapid-fire delivery, and therein lies the rub. Needless to say, this handsome volume of the proceedings is a welcome, detailed account of this impressive symposium and stands on its own as an important compendium of some of the current frontiers of cancer research.
The book contains twenty-eight papers (one speaker failed to contribute) which are grouped into seven parts, following the outline of the symposium. Part I, entitled "Alkylating Agents," begins with discussions of the mechanisms and targets of clinically relevant drugs such as the nitrogen mustards and platinum compounds by Drs. K.W. Kohn, J.J. Roberts, and K.R. Harrap. Particularly noteworthy in terms of
